Florian Eisner

2.1k total citations · 1 hit paper
23 papers, 1.5k citations indexed

About

Florian Eisner is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Florian Eisner has authored 23 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Cancer Research and 5 papers in Surgery. Recurrent topics in Florian Eisner's work include Cancer Genomics and Diagnostics (5 papers), Colorectal Cancer Treatments and Studies (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Florian Eisner is often cited by papers focused on Cancer Genomics and Diagnostics (5 papers), Colorectal Cancer Treatments and Studies (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Florian Eisner collaborates with scholars based in Austria, United States and Germany. Florian Eisner's co-authors include Martin Pichler, Hellmut Samonigg, Gerald Höefler, Carolin Lackner, Armin Gerger, Michael R. Speicher, Ellen Heitzer, Martina Auer, Peter Ulz and Jochen B. Geigl and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Florian Eisner

20 papers receiving 1.4k citations

Hit Papers

Increased neutrophil-lymphocyte ratio is a poor prognosti... 2013 2026 2017 2021 2013 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer
    2013 413 citations Michael Stotz, Armin Gerger et al. British Journal of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Florian Eisner Austria 10 989 806 409 334 260 23 1.5k
Gerhard Gebauer Germany 23 854 0.9× 517 0.6× 227 0.6× 237 0.7× 205 0.8× 49 1.4k
Carlo Messina Italy 23 829 0.8× 459 0.6× 540 1.3× 374 1.1× 401 1.5× 102 1.7k
Léonor Benhaïm France 20 745 0.8× 400 0.5× 438 1.1× 377 1.1× 677 2.6× 71 1.7k
Florian Clatot France 24 692 0.7× 461 0.6× 401 1.0× 321 1.0× 115 0.4× 99 1.6k
Hossein Saboorian United States 15 451 0.5× 367 0.5× 383 0.9× 302 0.9× 129 0.5× 24 1.1k
Thèrése Bocklage United States 23 418 0.4× 275 0.3× 396 1.0× 497 1.5× 221 0.8× 73 1.5k
Audrey Mansuet‐Lupo France 22 981 1.0× 321 0.4× 722 1.8× 462 1.4× 181 0.7× 64 1.8k
Olivier Dubreuil France 15 932 0.9× 382 0.5× 498 1.2× 310 0.9× 378 1.5× 56 1.6k
Richard Schulick United States 10 1.1k 1.1× 495 0.6× 252 0.6× 185 0.6× 528 2.0× 11 1.3k
Matthias Zitt Austria 20 528 0.5× 227 0.3× 487 1.2× 451 1.4× 417 1.6× 36 1.4k

Countries citing papers authored by Florian Eisner

Since Specialization
Citations

This map shows the geographic impact of Florian Eisner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian Eisner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian Eisner more than expected).

Fields of papers citing papers by Florian Eisner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florian Eisner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian Eisner. The network helps show where Florian Eisner may publish in the future.

Co-authorship network of co-authors of Florian Eisner

This figure shows the co-authorship network connecting the top 25 collaborators of Florian Eisner. A scholar is included among the top collaborators of Florian Eisner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florian Eisner. Florian Eisner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Posch, Florian, Eduard Schulz, Albert Wölfler, et al.. (2024). Ruxolitinib, IV Immunoglobulin, and High-Dose Glucocorticoids for Critically Ill Adults With Secondary Hemophagocytic Lymphohistiocytosis: A Single-Center Observational Pilot Study. Critical Care Explorations. 6(2). e1046–e1046. 3 indexed citations
2.
Reisinger, Alexander C., Stefan Hatzl, Juergen Prattes, et al.. (2023). Soluble urokinase plasminogen activator receptor (suPAR) in bronchoalveolar fluid and blood in critically ill patients—a prospective cohort study. Infection. 52(1). 249–252. 1 indexed citations
3.
Fabian, Elisabeth, Christoph Wenisch, Florian Eisner, et al.. (2021). Clinical-Pathological Conference Series from the Medical University of Graz. Wiener klinische Wochenschrift. 133(13-14). 731–740. 1 indexed citations
4.
Reinisch, Sabine, Florian Moik, Michael Stotz, et al.. (2020). Decrease in treatment intensity predicts worse outcome in patients with locally advanced head and neck squamous cell carcinoma undergoing radiochemotherapy. Clinical & Translational Oncology. 23(3). 543–553. 5 indexed citations
5.
Artinger, Katharina, Gerald Hackl, Gernot Schilcher, et al.. (2019). The conundrum of postpartum thrombotic Microangiopathy: case report and considerations for management. BMC Nephrology. 20(1). 91–91. 4 indexed citations
6.
Balić, Marija, Wolfgang Hilbe, Michael Fiegl, et al.. (2019). Prevalence of comorbidity in cancer patients scheduled for systemic anticancer treatment in Austria. memo - Magazine of European Medical Oncology. 12(4). 290–296. 8 indexed citations
7.
Theiler‐Schwetz, Verena, Florian Eisner, Gernot Schilcher, et al.. (2017). Combined metformin-associated lactic acidosis and euglycemic ketoacidosis. Wiener klinische Wochenschrift. 129(17-18). 646–649. 16 indexed citations
8.
Richtig, Georg, Ariane Aigelsreiter, Daniela Schwarzenbacher, et al.. (2017). SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types. PLoS ONE. 12(11). e0187814–e0187814. 46 indexed citations
9.
Fabian, Elisabeth, Florian Eisner, Ingrid Pabinger, et al.. (2015). Clinical-Pathological Conference Series from the Medical University of Graz Case No 155: 26-year-old woman in third trimester of pregnancy with epigastric pain and thrombocytopenia. Wiener klinische Wochenschrift. 127(17-18). 707–714. 1 indexed citations
10.
Eisner, Florian, Martin Pichler, Steffen Goletz, Herbert Stoeger, & Hellmut Samonigg. (2015). A glyco-engineered anti-HER2 monoclonal antibody (TrasGEX) induces a long-lasting remission in a patient with HER2 overexpressing metastatic colorectal cancer after failure of all available treatment options. Journal of Clinical Pathology. 68(12). 1044.1–1046. 6 indexed citations
11.
Mohan, Sumitra, Ellen Heitzer, Peter Ulz, et al.. (2014). Changes in Colorectal Carcinoma Genomes under Anti-EGFR Therapy Identified by Whole-Genome Plasma DNA Sequencing. PLoS Genetics. 10(3). e1004271–e1004271. 134 indexed citations
12.
Heitzer, Ellen, Martina Auer, Christin Gasch, et al.. (2013). Complex Tumor Genomes Inferred from Single Circulating Tumor Cells by Array-CGH and Next-Generation Sequencing. Cancer Research. 73(10). 2965–2975. 403 indexed citations
13.
Heitzer, Ellen, Peter Ulz, Jelena Belic, et al.. (2013). Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing. Genome Medicine. 5(4). 30–30. 263 indexed citations
14.
Szkandera, Joanna, Michael Stotz, Florian Eisner, et al.. (2013). External Validation of the Derived Neutrophil to Lymphocyte Ratio as a Prognostic Marker on a Large Cohort of Pancreatic Cancer Patients. PLoS ONE. 8(11). e78225–e78225. 86 indexed citations
15.
Stotz, Michael, Armin Gerger, Florian Eisner, et al.. (2013). Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. British Journal of Cancer. 109(2). 416–421. 413 indexed citations breakdown →
16.
Stotz, Michael, Florian Eisner, Joanna Szkandera, et al.. (2013). Clinico-pathological characteristics and clinical outcome of different histological types of pancreatic cancer in a large Middle European series. Journal of Clinical Pathology. 66(9). 753–757. 16 indexed citations
17.
Eisner, Florian, Renate Schaberl-Moser, Armin Gerger, Hellmut Samonigg, & Martin Pichler. (2013). Successful Use of Sorafenib after Bortezomib Failure in Metastatic Follicular Thyroid Cancer - a Case Report. Oncology Research and Treatment. 36(6). 368–370.
18.
Aigelsreiter, Ariane, Anna Lena Ress, Kira Bettermann, et al.. (2013). Low expression of the putative tumour suppressor spinophilin is associated with higher proliferative activity and poor prognosis in patients with hepatocellular carcinoma. British Journal of Cancer. 108(9). 1830–1837. 20 indexed citations
19.
Tse, Gary, Klara Belaj, Martin Pichler, et al.. (2012). Asymptomatic deep vein thrombosis and superficial vein thrombosis in ambulatory cancer patients: impact on short-term survival. British Journal of Cancer. 107(8). 1244–1248. 38 indexed citations
20.
Eisner, Florian, Michael Stotz, Hellmut Samonigg, et al.. (2012). Down-regulation of KRAS-interacting miRNA-143 to predict prognosis and response to EGFR-targeted agents in colorectal cancer.. Journal of Clinical Oncology. 30(15_suppl). e14066–e14066. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerhard Gebauer Breakdown of academic impact, for papers by Carlo Messina Breakdown of academic impact, for papers by Léonor Benhaïm Breakdown of academic impact, for papers by Florian Clatot Breakdown of academic impact, for papers by Hossein Saboorian Breakdown of academic impact, for papers by Thèrése Bocklage Breakdown of academic impact, for papers by Audrey Mansuet‐Lupo Breakdown of academic impact, for papers by Olivier Dubreuil Breakdown of academic impact, for papers by Richard Schulick Breakdown of academic impact, for papers by Matthias Zitt
Rankless by CCL
2026